Cargando…

Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2

Rationale: Tanshinone, a type of diterpenes derived from salvia miltiorrhiza, is a particularly promising herbal medicine compound for the treatment of cancers including acute myeloid leukemia (AML). However, the therapeutic function and the underlying mechanism of Tanshinone in AML are not clear, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ying, Yu, Shan-He, Zhen, Wen-Xuan, Cheng, Tao, Wang, Dan, Lin, Jie-Bo, Wu, Yu-Han, Wang, Yi-Fan, Chen, Yi, Shu, Li-Ping, Wang, Yi, Sun, Xiao-Jian, Zhou, Yi, Yang, Fan, Hsu, Chih-Hung, Xu, Peng-Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171091/ https://www.ncbi.nlm.nih.gov/pubmed/34093860 http://dx.doi.org/10.7150/thno.53170

Ejemplares similares

EZH2 in normal hematopoiesis and hematological malignancies
por: Herviou, Laurie, et al.
Publicado: (2015)

Chicken xenobiotic receptor upregulates the BCRP/ABCG2 transporter
por: Xu, Ziyong, et al.
Publicado: (2022)

Ezh2 promotes clock function and hematopoiesis independent of histone methyltransferase activity in zebrafish
por: Zhong, Yingbin, et al.
Publicado: (2018)

HOXB13 networking with ABCG1/EZH2/Slug mediates metastasis and confers resistance to cisplatin in lung adenocarcinoma patients
por: Zhan, Jun, et al.
Publicado: (2019)

YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells
por: Dai, Yuyuan, et al.
Publicado: (2016)

BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
por: Huang, Wei-Chien, et al.
Publicado: (2013)

NOS1 upregulates ABCG2 expression contributing to DDP chemoresistance in ovarian cancer cells
por: Li, Xiaoxuan, et al.
Publicado: (2019)

Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2
por: Wang, De-Shen, et al.
Publicado: (2014)

ABCG2 Localizes to the Nucleus and Modulates CDH1 Expression in Lung Cancer Cells()()()
por: Liang, Shu-Ching, et al.
Publicado: (2015)

EZH2 inhibitors abrogate upregulation of trimethylation of H3K27 by CDK9 inhibitors and potentiate its activity against diffuse large B-cell lymphoma
por: Xie, Shao, et al.
Publicado: (2020)

Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo
por: Kuang, Yan, et al.
Publicado: (2017)

EZH2-Mediated microRNA-375 Upregulation Promotes Progression of Breast Cancer via the Inhibition of FOXO1 and the p53 Signaling Pathway
por: Guan, Xin, et al.
Publicado: (2021)

Role of HDACs in normal and malignant hematopoiesis
por: Wang, Pan, et al.
Publicado: (2020)

Tanshinones induce tumor cell apoptosis via directly targeting FHIT
por: Zhou, Xianglian, et al.
Publicado: (2021)

The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
por: Wu, Shi-yi, et al.
Publicado: (2022)

Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011)

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
por: Zhao, Ende, et al.
Publicado: (2015)

Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma
por: Zhang, Yi, et al.
Publicado: (2014)

Normal and Neoplastic Hematopoiesis
por: Morin, Michael J.
Publicado: (1984)

Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancer
por: Luo, Lianghua, et al.
Publicado: (2023)

In Silico Prediction of Inhibition of Promiscuous Breast Cancer Resistance Protein (BCRP/ABCG2)
por: Ding, Yi-Lung, et al.
Publicado: (2014)

Gastrin/CCK-B Receptor Signaling Promotes Cell Invasion and Metastasis by Upregulating MMP-2 and VEGF Expression in Gastric Cancer
por: Zhao, Yan, et al.
Publicado: (2022)

The noncanonical role of EZH2 in cancer
por: Huang, Jinhua, et al.
Publicado: (2021)

HGK-sestrin 2 signaling-mediated autophagy contributes to antitumor efficacy of Tanshinone IIA in human osteosarcoma cells
por: Yen, Jia-Hau, et al.
Publicado: (2018)

IL-33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway
por: Zhang, Jian-Fei, et al.
Publicado: (2017)

Correction to: Role of HDACs in normal and malignant hematopoiesis
por: Wang, Pan, et al.
Publicado: (2020)

TET2: A cornerstone in normal and malignant hematopoiesis
por: Kunimoto, Hiroyoshi, et al.
Publicado: (2020)

Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression
por: Ye, Mujie, et al.
Publicado: (2022)

EZH2: biology, disease, and structure-based drug discovery
por: Tan, Jin-zhi, et al.
Publicado: (2014)

EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription
por: Ayoub, Edward, et al.
Publicado: (2018)

Depressive Disorder promotes Hepatocellular Carcinoma metastasis via upregulation of ABCG2 gene expression and maintenance of self-renewal
por: Hu, Hao, et al.
Publicado: (2020)

Tanshinone IIA May Inhibit Gastric Cancer via Affecting the Intestinal Microbiome
por: Lu, Fenggang, et al.
Publicado: (2022)

Tanshinone IIA inhibits angiogenesis in human endothelial progenitor cells in vitro and in vivo
por: Lee, Hsiang-Ping, et al.
Publicado: (2017)

LINC00565 promotes the progression of colorectal cancer by upregulating EZH2
por: Shao, Xiaxia, et al.
Publicado: (2021)

EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis
por: Shih, C-H, et al.
Publicado: (2017)

Exosome‐transmitted circ_MMP2 promotes hepatocellular carcinoma metastasis by upregulating MMP2
por: Liu, Dengrui, et al.
Publicado: (2020)

Epitranscriptomics in Normal and Malignant Hematopoiesis
por: Minervini, Crescenzio Francesco, et al.
Publicado: (2020)

Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription
por: Min, Jie, et al.
Publicado: (2022)

ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis
por: Wang, Anbin, et al.
Publicado: (2019)

Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice
por: Lu, Yun-hong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_siejt10hf2cqvb8o22ch3gck3u